Skip to main content

Advertisement

Table 3 Treatment modalities in young breast cancer patients (N = 144) and their associations with disease progression (HR hazard ratio, CI confidence interval)

From: Pathological profiles and clinical management challenges of breast cancer emerging in young women in Indonesia: a hospital-based study

Treatment modalities N % HR (95%CI)
Surgery
 Palliative 16 11.10% 2.915 (0.775–10.965)
 Radical 121 84% ref
 Conservative 7 4.90%
Chemotherapy
 Neoadjuvant 6 4.20% 1.667 (0.310–8.976)
 Adjuvant 98 68%
 Palliative 23 16%
 No 26 11.80% ref
Radiotherapy
 No 29 20.10% 0.836 (0.321–2.1770
 Waiting list 13 9%
 Yes 102 70.80% ref
Hormonal therapy
 Yes 49 34% ref
 No 8 5.60% 1.04 (0.49–2.207)
 HR-negative 86 59.700%
Anti-HER2 therapy
 HER2 positive 44 30.60%  
 No 26 18.10% 0.844 (0.203–3.504)
 Yes 18 12.50% ref
Bisphosphonate treatment
 Yes 17 11.80% N/A
 No 6 4.20% N/A
 Bone metastases 23 16%